{
    "id": "d5c7b59eda",
    "abstract": [],
    "body_text": [
        {
            "text": "Previous studies have demonstrated the importance of mitochondria and oxidative stress in the development of neuronal diseases, such as Parkinson's disease (PD) and Alzheimer's disease (1,2). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 185,
                    "end": 188,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "(1,"
                },
                {
                    "start": 188,
                    "end": 190,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "2)"
                }
            ]
        },
        {
            "text": "In human eyes, the retina is extremely vulnerable to oxidative damage. ",
            "section": "Introduction"
        },
        {
            "text": "Oxidative stress has been demonstrated to be the predominant mechanism associated with the pathogenesis of age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma and retinitis pigmentosa (RP) (3)(4)(5)(6). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 213,
                    "end": 216,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "(3)"
                },
                {
                    "start": 216,
                    "end": 219,
                    "type": "bibr",
                    "ref_id": "b3",
                    "text": "(4)"
                },
                {
                    "start": 219,
                    "end": 222,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "(5)"
                },
                {
                    "start": 222,
                    "end": 225,
                    "type": "bibr",
                    "ref_id": "b5",
                    "text": "(6)"
                }
            ]
        },
        {
            "text": "Novel strategies targeting mitochondria and reactive oxygen species (ROS) generation may provide promising prospects towards antioxidant therapy in these retinal diseases.",
            "section": "Introduction"
        },
        {
            "text": "A novel mitochondria-targeted peptide, MTP-131 (also known as SS-31 or Bendavia), originally designed by Hazel H. Szeto and Peter W. Schiller (7), is a water-soluble peptide with an alternating aromatic cationic motif (D-Arg-dimethylTyr-Lys-Phe-NH 2 ) and a 3+ net charge at physiological pH (8). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 142,
                    "end": 145,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "(7)"
                },
                {
                    "start": 292,
                    "end": 295,
                    "type": "bibr",
                    "ref_id": "b7",
                    "text": "(8)"
                }
            ]
        },
        {
            "text": "The fraction of the peptide partitioned to mitochondria has been estimated to be 1,000 to 5,000-fold compared with the extra-mitochondrial concentration, and the peptide is predominately localized to the inner mitochondrial membrane (7). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 233,
                    "end": 236,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "(7)"
                }
            ]
        },
        {
            "text": "MTP-131 reduces ROS production in a dose-dependent manner and prevents oxidative damage in neuronal cell lines (9). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 111,
                    "end": 114,
                    "type": "bibr",
                    "ref_id": "b8",
                    "text": "(9)"
                }
            ]
        },
        {
            "text": "In addition, treatment of mice with MTP-131 prevents loss of neurons and increases survival in PD and amyotrophic lateral sclerosis animal models (10).",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 146,
                    "end": 150,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "(10)"
                }
            ]
        },
        {
            "text": "Since MTP-131 has a unique mitochondria-targeted delivery, and exhibits potent antioxidant and neuroprotective effect both in vitro and in vivo, the present study aimed to evaluate the protective effect of MTP-131 against hydrogen peroxide (H 2 O 2 )-induced oxidative damage in RGC-5 cells.",
            "section": "Introduction"
        },
        {
            "text": "Lys-Phe-NH 2 ) was kindly provided by Stealth BioTherapeutics, Inc. (Newton, MA, USA). ",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "Gibco Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were obtained from Thermo Fisher Scientific (Waltham, MA, USA). ",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "Lactate dehydrogenase (LDH) assay kit was obtained from Roche Diagnostics Gmbh (Mannheim, Germany). ",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "Tetramethylrhodamine methyl ester perchlorate (TMRM), 2',7'-dichlorodihydrofluorescein diacetate (H 2 DCFDA) and MitoTracker Deep Red FM were obtained from Thermo Fisher Scientific, Inc. and prepared as 50 \u00b5M, 1 and 1 mM stock solutions in dimethyl sulfoxide, respectively. ",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) apoptosis assay kit was from Multisciences Lianke Biotech Co., Ltd. (Hangzhou, China). ",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "Unless specified, all other reagents were obtained from Sigma-Aldrich; Merck KGaA (Darmstadt, Germany).",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "Cell culture. ",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "The RGC-5 cell line was kindly provided by Dr Zhiqun Tan (Department of Neurology, UC Irvine School of Medicine, Irvine, CA, USA). ",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "Undifferentiated RGC-5 cells were used in the present study. ",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "Cells were cultured in DMEM containing 10% FBS, and 1% penicillin-streptomycin (100 U/ml penicillin and 100 \u00b5g/ml streptomycin) at 37\u02daC and 5% CO 2 . ",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "Cells were passaged by trypsinization every 3 days. ",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "All cell culture dishes and plates were obtained from BD Biosciences (Franklin Lakes, NJ, USA).",
            "section": "Reagents and chemicals. MTP-131 (D-Arg-(2'6'-dimethylTyr)-"
        },
        {
            "text": "RGC-5 cells were seeded at a density of 1x10 4 cells/well in 6-well plates and incubated in 5% CO 2 at 37\u02daC for 24 h. ",
            "section": "MTP-131 pretreatment and induction of oxidative stress."
        },
        {
            "text": "Cells at approximately 70% confluence were pretreated with 0.01, 0.1 or 1 \u00b5M MTP-131 in serum-free DMEM at 37\u02daC for 1 h and then rinsed twice with PBS. ",
            "section": "MTP-131 pretreatment and induction of oxidative stress."
        },
        {
            "text": "Then, RGC-5 cells were exposed to 500 \u00b5M H 2 O 2 in serum-free DMEM for 24 h to induce a sustained oxidative stress in vitro. ",
            "section": "MTP-131 pretreatment and induction of oxidative stress."
        },
        {
            "text": "Untreated cells and cells treated with H 2 O 2 alone were used as normal and H 2 O 2 control, respectively.",
            "section": "MTP-131 pretreatment and induction of oxidative stress."
        },
        {
            "text": "Measurement of cell viability. ",
            "section": "MTP-131 pretreatment and induction of oxidative stress."
        },
        {
            "text": "Cell viability was assessed by LDH assay using the Cytotoxicity Detection kitPLUS (Roche Diagnostics Gmbh) according to the manufacturer's instructions and as described previously (11). ",
            "section": "MTP-131 pretreatment and induction of oxidative stress.",
            "ref_spans": [
                {
                    "start": 180,
                    "end": 184,
                    "type": "bibr",
                    "ref_id": "b10",
                    "text": "(11)"
                }
            ]
        },
        {
            "text": "Briefly, RGC-5 cells were seeded in 96-well plates at a density of 5x10 3 /well, and treated as described above. ",
            "section": "MTP-131 pretreatment and induction of oxidative stress."
        },
        {
            "text": "Culture supernatant (50 \u00b5l) from each well was transferred to a new 96-well plate and 100 \u00b5l reaction mixture solution was added to each well. ",
            "section": "MTP-131 pretreatment and induction of oxidative stress."
        },
        {
            "text": "Following incubation at room temperature in the dark for 30 min, 50 \u00b5l of stop solution was added to each well to terminate the reaction. ",
            "section": "MTP-131 pretreatment and induction of oxidative stress."
        },
        {
            "text": "Absorbance was measured using a microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA), at 490 nm test wavelength and at 630 nm reference wavelength. ",
            "section": "MTP-131 pretreatment and induction of oxidative stress."
        },
        {
            "text": "Cell viability was estimated as follows: cytotoxicity (%) = (experimental value-low control) / (high control-low control) x100%.",
            "section": "MTP-131 pretreatment and induction of oxidative stress."
        },
        {
            "text": ". TMRM, a cationic fluorescent probe which is taken up by mitochondria in a potential-dependent manner, was used to evaluate \u0394\u03a8m, as described previously (9). To quantify \u0394\u03a8m by flow cytometry, RGC-5 cells (1x10 4 cells/well in a 6-well plate) were pretreated with 0.01, 0.1 or 1 \u00b5M MTP-131 for 1 h and then incubated with 500 \u00b5M H 2 O 2 for 2 h. Cells were harvested and suspended in freshly prepared TMRM (200 nM) in phenol red and serum-free DMEM for 30 min at 37\u02daC in the dark. All samples were rinsed twice with PBS and analyzed immediately by flow cytometry using a FACSAria II (BD Biosciences, Franklin Lakes, NJ, USA) and excitation/emission (ex/em) wavelengths 548/573 nm. A total of 1x10 4 cells were routinely collected, and results were expressed in arbitrary units as the mean fluorescence intensity (MFI) from the average of at least three separate experiments.",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)",
            "ref_spans": [
                {
                    "start": 154,
                    "end": 157,
                    "type": "bibr",
                    "ref_id": "b8",
                    "text": "(9)"
                }
            ]
        },
        {
            "text": "For confocal microscopy, RGC-5 cells were plated in Petri dishes. ",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "Following MTP-131 pretreatment and H 2 O 2 incubation, cells were rinsed twice and loaded with freshly prepared 500 nM TMRM for 30 min at 37\u02daC in the dark. ",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "Following two rinses with PBS, cells were visualized by confocal microscopy using a LSM 510 microscope (Carl Zeiss AG, Oberkochen, Germany) and ex/m wavelengths 548/573 nm.",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "Measurement of intracellular ROS. ",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "Intracellular ROS in RGC-5 cells was measured with H 2 DCFDA, as described previously (12). ",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)",
            "ref_spans": [
                {
                    "start": 86,
                    "end": 90,
                    "type": "bibr",
                    "ref_id": "b11",
                    "text": "(12)"
                }
            ]
        },
        {
            "text": "This nonfluorescent probe accumulates within cells and transforms into 2',7'-dichlorodihydrofluorescein (H 2 DCF) by deacetylation, which then reacts with ROS to form the fluorescent dichlorofluorescein (DCF). ",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "To quantify ROS by flow cytometry, RGC-5 cells (1x10 4 cells/well in a 6-well plate) were pretreated with 0.01, 0.1 or 1 \u00b5M MTP-131 for 1 h and then incubated with 500 \u00b5M H 2 O 2 for 24 h. ",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "Cells were harvested and suspended in freshly prepared H 2 DCFDA (5 \u00b5M) in phenol red and serum-free DMEM for 30 min at 37\u02daC in the dark. ",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "All samples were rinsed twice with PBS and analyzed immediately by flow cytometry (ex/em: 488/530 nm). ",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "Ten thousand cells were routinely collected, and results were expressed as the MFI in arbitrary units from the average of at least three separate experiments.",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "For visualization by confocal microscopy, cells were plated in Petri dishes. ",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "Following pretreatment with MTP-131 and incubation with H 2 O 2 , 5 \u00b5M freshly prepared H 2 DCFDA was added into cells and incubated at 37\u02daC for 30 min in the dark. ",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "Following two rinses with PBS, cells were immediately imaged by confocal microscopy (ex/em: 495/525 nm).",
            "section": "Measurement of mitochondrial membrane potential changes (\u0394\u03a8m)"
        },
        {
            "text": "an Annexin V-FITC/PI apoptosis assay kit, according to the manufacturer's instructions. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Briefly, cells were pretreated with 0.01, 0.1 or 1 \u00b5M MTP-131 for 1 h and then incubated with 500 \u00b5M H 2 O 2 for 4, 8, 12 and 24 h. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "To quantify apoptosis by flow cytometry, cells were collected by trypsinization and centrifugation (100 x g for 5 min, at room temperature) at the appropriate time point. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Following two rinses with PBS, cells were resuspended in 500 \u00b5l loading buffer and incubated with 5 \u00b5l Annexin V and 10 \u00b5l PI at room temperature for 5 min in the dark. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Flow cytometry analysis was immediately performed (ex/em: 488/530 nm), using a FITC signal detector (FL1 channel) and PI emission signal detector (FL2 channel) to analyze Annexin V-FITC binding and PI staining, respectively. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "A total of 1x10 4 cells were collected and divided into four groups: viable cells (Annexin V -/PI -, Q3), early apoptotic cells (Annexin V + /PI -, Q4), late apoptotic cells (Annexin V + /PI + , Q2) or dead cells (Annexin V -/PI + , Q1). ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "The apoptotic rate was calculated as the sum of the percentages of early apoptotic cells (Q4) and late apoptotic cells (Q2).",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Measurement of cytochrome c release. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "The release of cytochrome c from mitochondria to the cytoplasm was measured by confocal microscopy as previously described (13). ",
            "section": "Measurement of apoptosis. Apoptosis was measured using",
            "ref_spans": [
                {
                    "start": 123,
                    "end": 127,
                    "type": "bibr",
                    "ref_id": "b12",
                    "text": "(13)"
                }
            ]
        },
        {
            "text": "Briefly, cells were seeded onto Fisherbrand cover glass (Thermo Fisher Scientific, Inc.) at a density of 2,000 cells/chamber. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Following pretreatment with 1 \u00b5M MTP-131 for 1 h, cells were incubated in the presence or absence of 500 \u00b5M H 2 O 2 for 6 h at 37\u02daC in 5% CO 2 . ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Freshly prepared MitoTracker (500 nm) was added to the cells and incubated for 30 min, just before the end of the 6 h incubation period. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Cells were rinsed twice with PBS and fixed in 4% paraformaldehyde for 15 min, followed by 5 min permeabilization with methanol on ice. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Following blocking with 5% bovine serum albumin (BSA, Jackson ImmunoResearch Europe Ltd. Suffolk, UK) for 30 min, cells were incubated with mouse monoclonal anti-cytochrome c antibody (sc-4280; 1:100, diluted with 1% BSA; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) at 4\u02daC overnight. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Following three rinses with PBS, cells were incubated with DyLight 488-conjugated goat anti-mouse immunoglobulin G antibody (85-11-4011-85; 1:500, diluted with 1% BSA; Multisciences Lianke Biotech Co., Ltd.) for 30 min at 37\u02daC in the dark. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Finally, cells were stained with Hoechst 33342 (1:1,000, Thermo Fisher Scientific, Inc.) for 5 min, washed and mounted with anti-fade fluorescence mounting medium (Applygen Technologies, Inc., Beijing, China). ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Images were visualized by confocal microscopy. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Translocation of cytochrome c from mitochondria to cytoplasm was analyzed by overlapping staining of cytochrome c and MitoTracker. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "In each group, six slides were selected and five fields of view from each were assessed.",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Analysis of cell morphology. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "RGC-5 cells were seeded at a density of 1x10 4 cells/well on a 6-well plate. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Following pretreatment with 1 \u00b5M MTP-131 for 1 h and subsequent treatment with 500 \u00b5M H 2 O 2 for 24 h, micrographs of all cultures were captured using a Zeiss LSM 510 Cell Observer system (Carl Zeiss, AG) to examine changes in cell morphology.",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Statistical analysis. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "All assays were performed in at least three independent experiments and data are presented as the mean + standard error of the mean. ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Statistical analysis was performed by one-way analysis of variance and Newman-Keuls multiple comparison test, using GraphPad Prism 5.0 software (GraphPad Software Inc., La Jolla, CA, USA). ",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "P<0.05 was considered to indicate a statistically significant difference.",
            "section": "Measurement of apoptosis. Apoptosis was measured using"
        },
        {
            "text": "Apoptosis was measured by Annexin V-FITC/PI staining and  (Fig. 4 and Table I). ",
            "section": "MTP-131 treatment protects against H 2 O 2 -induced apoptosis.",
            "ref_spans": [
                {
                    "start": 58,
                    "end": 65,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "(Fig. 4"
                },
                {
                    "start": 70,
                    "end": 77,
                    "type": "table",
                    "ref_id": "tab_0",
                    "text": "Table I"
                }
            ]
        },
        {
            "text": "Pretreatment with 1 and 0.1 \u00b5M MTP-131 inhibited H 2 O 2 -induced apoptosis at 4, 8, 12 and 24 h compared with cells treated with H 2 O 2 alone at the same time points (P<0.001 compared with H 2 O 2 alone; Fig. 4 and Table I). ",
            "section": "MTP-131 treatment protects against H 2 O 2 -induced apoptosis.",
            "ref_spans": [
                {
                    "start": 206,
                    "end": 212,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "Fig. 4"
                },
                {
                    "start": 217,
                    "end": 224,
                    "type": "table",
                    "ref_id": "tab_0",
                    "text": "Table I"
                }
            ]
        },
        {
            "text": "Pretreatment with 0.01 \u00b5M MTP-131 also alleviated apoptosis at 4 and 8 h following H 2 O 2 incubation, but no effect was observed at 12 and 24 h compared with cells treated with H 2 O 2 alone ( Fig. 4 and Table I).  ",
            "section": "MTP-131 treatment protects against H 2 O 2 -induced apoptosis.",
            "ref_spans": [
                {
                    "start": 194,
                    "end": 200,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "Fig. 4"
                },
                {
                    "start": 205,
                    "end": 212,
                    "type": "table",
                    "ref_id": "tab_0",
                    "text": "Table I"
                }
            ]
        },
        {
            "text": "(Fig. 5).  ",
            "section": "MTP-131 treatment protects against H 2 O 2 -induced apoptosis.",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 8,
                    "type": "figure",
                    "ref_id": "fig_3",
                    "text": "(Fig. 5)"
                }
            ]
        },
        {
            "text": "Fig. 6).",
            "section": "MTP-131 treatment protects against H 2 O 2 -induced apoptosis.",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 6,
                    "type": "figure",
                    "ref_id": "fig_7",
                    "text": "Fig. 6"
                }
            ]
        },
        {
            "text": "In the present study, the antioxidant effect of MTP-131 against H 2 O 2 -induced sustained oxidative stress was examined in undifferentiated RGC-5 cells. ",
            "section": "Discussion"
        },
        {
            "text": "The present findings demonstrated that MTP-131 treatment prevented mitochondrial depolarization, decreased intracellular ROS production, and inhibited apoptosis induced by sustained oxidative stress in RGC-5 cells. ",
            "section": "Discussion"
        },
        {
            "text": "H 2 O 2 is widely used to induce oxidative stress in experimental studies, leading to an increase in intracellular accumulation of ROS and RGC apoptosis (14)(15)(16). ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 153,
                    "end": 157,
                    "type": "bibr",
                    "ref_id": "b13",
                    "text": "(14)"
                },
                {
                    "start": 157,
                    "end": 161,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "(15)"
                },
                {
                    "start": 161,
                    "end": 165,
                    "type": "bibr",
                    "ref_id": "b15",
                    "text": "(16)"
                }
            ]
        },
        {
            "text": "In the present study, H 2 O 2 (500 \u00b5M for 24 h) was used to induce a sustained oxidative stress, and was demonstrated to cause significant cell damage in RGC-5 cells, which is consistent    with previous studies (14). ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 212,
                    "end": 216,
                    "type": "bibr",
                    "ref_id": "b13",
                    "text": "(14)"
                }
            ]
        },
        {
            "text": "MTP-131 pretreatment protected RGC-5 cells from mitochondrial membrane depolarization, reduced ROS production and inhibited cytochrome c release from mitochondria to cytoplasm. ",
            "section": "Discussion"
        },
        {
            "text": "These effects were demonstrated to alleviate apoptosis in RGC-5 cells, thus suggesting that MTP-131 exhibited a potential protective effect against oxidative stress in RGC-5 cells through direct inhibition of mitochondria-mediated pathways. ",
            "section": "Discussion"
        },
        {
            "text": "RGC-5 cells have been widely used in in vitro experimental studies (17)(18)(19). ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 67,
                    "end": 71,
                    "type": "bibr",
                    "ref_id": "b16",
                    "text": "(17)"
                },
                {
                    "start": 71,
                    "end": 75,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "(18)"
                },
                {
                    "start": 75,
                    "end": 79,
                    "type": "bibr",
                    "ref_id": "b18",
                    "text": "(19)"
                }
            ]
        },
        {
            "text": "However, the validity of this cell line is now questioned. ",
            "section": "Discussion"
        },
        {
            "text": "It has been demonstrated that the RGC-5 cell line is of mouse origin, not rat as it was first described, and that it express photoreceptor markers instead of retinal ganglion markers (20,21). ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 183,
                    "end": 187,
                    "type": "bibr",
                    "ref_id": "b19",
                    "text": "(20,"
                },
                {
                    "start": 187,
                    "end": 190,
                    "type": "bibr",
                    "ref_id": "b20",
                    "text": "21)"
                }
            ]
        },
        {
            "text": "However, RGC-5 cells still have several properties in common with retinal progenitor cells and is therefore appropriate for neuronal cell studies (20). ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 146,
                    "end": 150,
                    "type": "bibr",
                    "ref_id": "b19",
                    "text": "(20)"
                }
            ]
        },
        {
            "text": "A series of retinal disorders have been related to oxidative damage, such as AMD, DR and RP (3,4,6). ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 92,
                    "end": 95,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "(3,"
                },
                {
                    "start": 95,
                    "end": 97,
                    "type": "bibr",
                    "ref_id": "b3",
                    "text": "4,"
                },
                {
                    "start": 97,
                    "end": 99,
                    "type": "bibr",
                    "ref_id": "b5",
                    "text": "6)"
                }
            ]
        },
        {
            "text": "The retina is constantly exposed to visible light, which makes it extremely vulnerable to oxidative damage, due to its great energy demands and high oxygen consumption (5). ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 168,
                    "end": 171,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "(5)"
                }
            ]
        },
        {
            "text": "A previous study have demonstrated that oxidative stress is extremely important in the retinal pigment epithelium (RPE) cells. ",
            "section": "Discussion"
        },
        {
            "text": "ROS induces mitochondrial dysfunction in RPE, leading to RPE cell apoptosis and death of photoreceptor cells (22).",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 109,
                    "end": 113,
                    "type": "bibr",
                    "ref_id": "b21",
                    "text": "(22)"
                }
            ]
        },
        {
            "text": "Compared with traditional antioxidants, MTP-131 represents the only known class of cell-permeable compounds that specifically concentrates in the inner mitochondrial membrane (7). ",
            "section": "H 2 O 2 (500 \u00b5M)+MTP-131 (\u00b5M) -------------------------------------------------------------------------------------------------",
            "ref_spans": [
                {
                    "start": 175,
                    "end": 178,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "(7)"
                }
            ]
        },
        {
            "text": "With a 3+ net charge, MTP-131 selectively binds to cardiolipin and modulates its interaction with cytochrome c. ",
            "section": "H 2 O 2 (500 \u00b5M)+MTP-131 (\u00b5M) -------------------------------------------------------------------------------------------------"
        },
        {
            "text": "By inhibiting the cytochrome c/cardiolipin complex peroxidase activity, MTP-131 optimizes mitochondrial electron transport and ATP synthesis (23,24). ",
            "section": "H 2 O 2 (500 \u00b5M)+MTP-131 (\u00b5M) -------------------------------------------------------------------------------------------------",
            "ref_spans": [
                {
                    "start": 141,
                    "end": 145,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "(23,"
                },
                {
                    "start": 145,
                    "end": 148,
                    "type": "bibr",
                    "ref_id": "b23",
                    "text": "24)"
                }
            ]
        },
        {
            "text": "Numerous in vitro and animal studies have demonstrated the remarkable efficacy of MTP-131 in age-associated diseases. ",
            "section": "H 2 O 2 (500 \u00b5M)+MTP-131 (\u00b5M) -------------------------------------------------------------------------------------------------"
        },
        {
            "text": "For example, daily treatment with MTP-131 reverses mitochondrial dysfunction and inhibits neuronal apoptosis and inflammation in mice with sepsis-associated encephalopathy (25). ",
            "section": "H 2 O 2 (500 \u00b5M)+MTP-131 (\u00b5M) -------------------------------------------------------------------------------------------------",
            "ref_spans": [
                {
                    "start": 172,
                    "end": 176,
                    "type": "bibr",
                    "ref_id": "b24",
                    "text": "(25)"
                }
            ]
        },
        {
            "text": "In addition, MTP-131 exhibits protective effects against cardiac ischemia-reperfusion injury (26). ",
            "section": "H 2 O 2 (500 \u00b5M)+MTP-131 (\u00b5M) -------------------------------------------------------------------------------------------------",
            "ref_spans": [
                {
                    "start": 93,
                    "end": 97,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "(26)"
                }
            ]
        },
        {
            "text": "The effectiveness of cardiolipin combined with MTP-131 is currently being evaluated in a multinational clinical trial for reperfusion injury in patients with acute   coronary events (ClinicalTrials.gov Identifier: NCT01572909), and a Phase 2 trial is underway assessing the effectiveness of MTP-131 on improving renal function following angioplasty for severe renal artery stenosis (ClinicalTrials.gov Identifier: NCT01755858) (27). ",
            "section": "H 2 O 2 (500 \u00b5M)+MTP-131 (\u00b5M) -------------------------------------------------------------------------------------------------",
            "ref_spans": [
                {
                    "start": 427,
                    "end": 431,
                    "type": "bibr",
                    "ref_id": "b26",
                    "text": "(27)"
                }
            ]
        },
        {
            "text": "Since MTP-131 has a unique mitochondria-targeted delivery, and exhibits potent antioxidant and neuroprotective effects both in vitro and in vivo, the present study aimed to evaluate the protective effect of MTP-131 against H 2 O 2 -induced oxidative damage in RGC-5 cells. ",
            "section": "H 2 O 2 (500 \u00b5M)+MTP-131 (\u00b5M) -------------------------------------------------------------------------------------------------"
        },
        {
            "text": "The present findings demonstrated that MTP-131 inhibited H 2 O 2 -induced mitochondria depolarization, reduced intracellular ROS and prevented apoptosis in RGC-5 cells.",
            "section": "H 2 O 2 (500 \u00b5M)+MTP-131 (\u00b5M) -------------------------------------------------------------------------------------------------"
        },
        {
            "text": "In conclusion, this novel class of targeted peptide therapeutics, including MTP-131, has the potential to restore mitochondrial bioenergetics. ",
            "section": "H 2 O 2 (500 \u00b5M)+MTP-131 (\u00b5M) -------------------------------------------------------------------------------------------------"
        },
        {
            "text": "Further studies using animal models will be needed in order to fully explore this novel antioxidant approach for the treatment of age-related retinal diseases.",
            "section": "H 2 O 2 (500 \u00b5M)+MTP-131 (\u00b5M) -------------------------------------------------------------------------------------------------"
        },
        {
            "text": "The authors would like to thank Stealth Peptides International Inc. for providing us with MTP-131 and a research grant. ",
            "section": "Acknowledgements"
        },
        {
            "text": "The present study was supported by the Zhejiang Provincial Natural Science Foundation of China (grant nos. LQ15H120001 and LY12H12008) and the National Natural Science Foundation of China (grant no. 81372930).",
            "section": "Acknowledgements"
        }
    ]
}